Carfilzomib Is Safe in Elderly Patients with Multiple Myeloma but Thrombotic Microangiopathy Is Underestimated in Clinical Practice

被引：0
|
作者：
Terao, Toshiki [1 ]
Tsushima, Takafumi [1 ]
Miura, Daisuke [2 ]
Ikeda, Daisuke [3 ]
Fukumoto, Ami [3 ]
Kuzume, Ayumi [1 ]
Tabata, Rikako [1 ]
Narita, Kentaro [2 ]
Takeuchi, Masami [1 ]
Matsue, Kosei [4 ]
机构：
[1] Kameda Med Ctr, Div Hematol Oncol, Kamogawa, Japan
[2] Kameda Med Ctr, Div Hematol Oncol, Dept Med, Kamogawa, Japan
[3] Kameda Med Ctr, Kamogawashi, Japan
[4] Kameda Gen Hosp, Div Hematol Oncol, Kamogawa, Japan
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-146460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3798
引用
收藏
页码：3798 / +
页数：5
相关论文
共 50 条
  • [21] Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review
    Cegledi, Andrea
    Kiraly, Agnes
    Varkonyi, Andrea
    Tasnady, Szabolcs
    Andrikovics, Hajnalka
    Fekete, Monika
    Szabo, Balint G.
    Szemlaky, Zsuzsanna
    Szilagyi, Agnes
    Sinkovits, Gyorgy
    Prohaszka, Zoltan
    Reti, Marienn
    Mikala, Gabor
    PHARMACEUTICALS, 2024, 17 (12)
  • [22] Carfilzomib Is Safe and Effective in Newly Diagnosed Patients with Multiple Myeloma with Renal Involvement
    Diamond, Benjamin
    Jayabalan, David S.
    Pearse, Roger
    Perry, Art
    Pekle, Karen
    Niesvizky, Ruben
    Rossi, Adriana C.
    BLOOD, 2017, 130
  • [23] Therapeutic management of multiple myeloma in routine clinical practice: which place for carfilzomib ?
    Ducret, Elodie
    Martelli, Sonia
    Bruneau, Antoine
    Garderet, Laurent
    Joly, Anne-Christine
    Fernandez, Christine
    Baylatry, Minh-Tam
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 305 - 306
  • [24] CLINICAL PRACTICE FOR MULTIPLE MYELOMA PATIENTS
    Petrucci, M. T.
    HAEMATOLOGICA, 2021, 106 (10) : 227 - 229
  • [25] Snakebite Associated Thrombotic Microangiopathy and Recommendations for Clinical Practice
    Noutsos, Tina
    Currie, Bart J.
    Wijewickrama, Eranga S.
    Isbister, Geoffrey K.
    TOXINS, 2022, 14 (01)
  • [26] Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma
    Chan, Kah-Lok
    Filshie, Robin
    Nandurkar, Harshal
    Quach, Hang
    LEUKEMIA & LYMPHOMA, 2015, 56 (07) : 2185 - 2186
  • [27] Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
    Salmenniemi, Urpu
    Remes, Kari
    HEMATOLOGY REPORTS, 2012, 4 (02) : 37 - 38
  • [28] Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma
    Van Keer, Jan
    Delforge, Michel
    Dierickx, Daan
    Peerlinck, Kathelijne
    Lerut, Evelyne
    Sprangers, Ben
    CASE REPORTS IN HEMATOLOGY, 2016, 2016
  • [29] Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma
    Morita, Rena
    Hashino, Satoshi
    Shirai, Shinichi
    Fujita, Noriaki
    Onozawa, Masahiro
    Kahata, Kaoru
    Kondo, Takeshi
    Imamura, Masahiro
    Asaka, Masahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (02) : 248 - 250
  • [30] Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma
    Rena Morita
    Satoshi Hashino
    Shinichi Shirai
    Noriaki Fujita
    Masahiro Onozawa
    Kaoru Kahata
    Takeshi Kondo
    Masahiro Imamura
    Masahiro Asaka
    International Journal of Hematology, 2008, 88 : 248 - 250
12345